Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4033)
All Articles published online
|
Oct 14, 2006 (publication date) through Sep 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Panteris V, Perdiou A, Tsirimpis V, Karamanolis DG. Acute coronary syndrome after infliximab therapy in a patient with Crohn’s disease. World J Gastroenterol 2006; 12(38): 6235-6238 [PMID: 17036404 DOI: 10.3748/wjg.v12.i38.6235] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i38/6235.htm |
| Number | Citing Articles |
| 1 |
Sumeet Gandhi, Neeraj Narula, John K. Marshall, Michael Farkouh. Are Patients with Inflammatory Bowel Disease at Increased Risk of Coronary Artery Disease?. The American Journal of Medicine 2012; 125(10): 956 doi: 10.1016/j.amjmed.2012.03.015
|
| 2 |
SreyRam Kuy, Anahita Dua, Rohit Chappidi, Gary Seabrook, Kellie R Brown, Brian Lewis, Peter J Rossi, Cheong J Lee. The increasing incidence of thromboembolic events among hospitalized patients with inflammatory bowel disease. Vascular 2015; 23(3): 260 doi: 10.1177/1708538114541799
|
| 3 |
Ravi Rasalingam, Ibrahim M. Saeed, Pamela K. Woodard, Julio E. Pérez. Left Ventricular Thrombus in the Setting of Normal Left Ventricular Function in Patients with Crohn's Disease. Echocardiography 2016; 33(1): 145 doi: 10.1111/echo.13081
|
| 4 |
Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 2007; 16(5) doi: 10.1002/pds.1374
|
| 5 |
Charles N. Bernstein, Andre Wajda, James F. Blanchard. The Incidence of Arterial Thromboembolic Diseases in Inflammatory Bowel Disease: A Population-Based Study. Clinical Gastroenterology and Hepatology 2008; 6(1): 41 doi: 10.1016/j.cgh.2007.09.016
|
| 6 |
Juri Tatsuoka, Takahiro Igarashi, Ryuta Kajimoto, Masato Kobayashi, Nobuhiro Moro, Takeshi Suma, Hideki Oshima, Atsuo Yoshino. High-dose-infliximab-associated Cerebral Venous Sinus Thrombosis: A Case Report and Review of the Literature. Internal Medicine 2021; 60(16): 2677 doi: 10.2169/internalmedicine.6447-20
|
| 7 |
Ashok Kumar, Tapan Ghose, Naval Mendiratta, Pradip K. Prajapati, Anil Abrol. Acute coronary syndrome caused by infliximab in a patient with ankylosing spondylitis. International Journal of Rheumatic Diseases 2013; 16(2): 235 doi: 10.1111/1756-185X.12052
|
| 8 |
Soner Senel, Veli Cobankara, Ozgur Taskoylu, Aydin Guclu, Harun Evrengul, Mehmet Gungor Kaya. Effect of Infliximab Treatment on QT Intervals in Patients with Ankylosing Spondylitis. Journal of Investigative Medicine 2011; 59(8): 1273 doi: 10.2310/JIM.0b013e3182330720
|
| 9 |
Eleftheria M. Mastoridou, Fotios S. Fousekis, Xenofon M. Sakellariou, Konstantinos Mpakogiannis, Dimitrios N. Nikas, Lampros K. Michalis, Konstantinos H. Katsanos, Haralampos Milionis. The Cardiovascular Effects of Inflammatory Bowel Disease Therapy with Biologics and Small Molecules: A Comprehensive Review. Journal of Clinical Medicine 2025; 14(18): 6476 doi: 10.3390/jcm14186476
|
| 10 |
Dimitri Renard, Luc Cornillet, Giovanni Castelnovo. Myocardial infarction after rituximab infusion. Neuromuscular Disorders 2013; 23(7): 599 doi: 10.1016/j.nmd.2013.03.014
|
| 11 |
Martin Rebolledo Del Toro, Camila Borda, Luisa Fernanda Rincón, Andrea Castillo, Daniel Gerardo Fernández-Ávila. Síndrome coronario agudo recurrente tras infusión de infliximab en paciente con artritis reumatoide. Colombia Medica 2023; 54(2): e5005466 doi: 10.25100/cm.v54i2.5466
|
| 12 |
Lindsey Sellers Coppiano, Dianne May. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. Side Effects of Drugs Annual 2022; 44: 379 doi: 10.1016/bs.seda.2022.09.012
|
| 13 |
Pietro Enea Lazzerini, Pier Leopoldo Capecchi, Mauro Galeazzi, Franco Laghi-Pasini. Biologic drugs and arrhythmic risk in chronic inflammatory arthritis: the good and the bad. Immunologic Research 2017; 65(1): 262 doi: 10.1007/s12026-016-8833-7
|
| 14 |
Nadine Petitpain, Nathalie Bornert-Keller, Laurent Peyrin-Biroulet. Acute coronary syndrome in a Crohn's disease patient treated with adalimumab. Journal of Crohn's and Colitis 2013; 7(9): e396 doi: 10.1016/j.crohns.2013.02.011
|
| 15 |
Sudeep D. Thapa, Hiba Hadid, Waseem Imam, Jason Schairer, Syed-Mohammed Jafri. Effect of Inflammatory Bowel Disease–Related Characteristics and Treatment Interventions on Cardiovascular Disease Incidence. The American Journal of the Medical Sciences 2015; 350(3): 175 doi: 10.1097/MAJ.0000000000000535
|
| 16 |
C. Lê Quang, M. Kouzez, C. Welsch, R. Ravan, N. Ferrier, P. Cassan, X. Marcaggi, G. Amat. Myopéricardite ou nécrose sous-endocardique : apport de l’imagerie par résonance magnétique illustré par un cas clinique. Annales de Cardiologie et d'Angéiologie 2008; 57(5): 307 doi: 10.1016/j.ancard.2008.08.009
|